Literature DB >> 21415853

Clonal hierarchy and allelic mutation segregation in a myelofibrosis patient with two distinct LNK mutations.

T L Lasho, A Tefferi, C Finke, A Pardanani.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21415853     DOI： 10.1038/leu.2011.45

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  11 in total

Review 1.  Normal and malignant megakaryopoiesis.

Authors:  Qiang Wen; Benjamin Goldenson; John D Crispino
Journal:  Expert Rev Mol Med       Date:  2011-10-21       Impact factor: 5.600

2.  Increased likelihood of post-polycythemia vera myelofibrosis in Ph-negative MPN patients with chromosome 12 abnormalities.

Authors:  Christopher B Benton; Maria Tanaka; Catherine Wilson; Sherry Pierce; Lingsha Zhou; Jorge Cortes; Hagop Kantarjian; Srdan Verstovsek
Journal:  Leuk Res       Date:  2015-02-02       Impact factor: 3.156

Review 3.  The role of LNK/SH2B3 genetic alterations in myeloproliferative neoplasms and other hematological disorders.

Authors:  N Maslah; B Cassinat; E Verger; J-J Kiladjian; L Velazquez
Journal:  Leukemia       Date:  2017-05-09       Impact factor: 11.528

Review 4.  The secret life of a megakaryocyte: emerging roles in bone marrow homeostasis control.

Authors:  Alessandro Malara; Vittorio Abbonante; Christian A Di Buduo; Lorenzo Tozzi; Manuela Currao; Alessandra Balduini
Journal:  Cell Mol Life Sci       Date:  2015-01-09       Impact factor: 9.261

5.  SH2B3 (LNK) mutations from myeloproliferative neoplasms patients have mild loss of function against wild type JAK2 and JAK2 V617F.

Authors:  Maya Koren-Michowitz; Sigal Gery; Takayuki Tabayashi; Dechen Lin; Rocio Alvarez; Arnon Nagler; H Phillip Koeffler
Journal:  Br J Haematol       Date:  2013-04-17       Impact factor: 6.998

6.  Idiopathic hypereosinophilia is clonal disorder? Clonality identified by targeted sequencing.

Authors:  Jee-Soo Lee; Heewon Seo; Kyongok Im; Si Nae Park; Sung-Min Kim; Eun Kyoung Lee; Jung-Ah Kim; Joon-Hee Lee; Sunghoon Kwon; Miyoung Kim; Insong Koh; Seungwoo Hwang; Heung-Woo Park; Hye-Ryun Kang; Kyoung Soo Park; Ju Han Kim; Dong Soon Lee
Journal:  PLoS One       Date:  2017-10-31       Impact factor: 3.240

Review 7.  JAK2 mutants (e.g., JAK2V617F) and their importance as drug targets in myeloproliferative neoplasms.

Authors:  Karoline Gäbler; Iris Behrmann; Claude Haan
Journal:  JAKSTAT       Date:  2013-05-14

8.  Molecular genetics of myelofibrosis and its associated disease phenotypes.

Authors:  Ali Tabarroki; Ramon V Tiu
Journal:  Transl Med UniSa       Date:  2014-02-04

9.  Mutational analysis of SH2B3 in Korean patients with BCR-ABL1 negative myeloproliferative neoplasm.

Authors:  Namhee Kim; In Suk Kim; Chulhun Ludgerus Chang; Eun Yup Lee; Hyung Hoi Kim; Moo Kon Song; Ho Jin Shin; Joo Seop Chung
Journal:  Ann Lab Med       Date:  2016-01       Impact factor: 3.464

10.  Assessment of the clinical utility of four NGS panels in myeloid malignancies. Suggestions for NGS panel choice or design.

Authors:  Almudena Aguilera-Diaz; Iria Vazquez; Beñat Ariceta; Amagoia Mañú; Zuriñe Blasco-Iturri; Sara Palomino-Echeverría; María José Larrayoz; Ramón García-Sanz; María Isabel Prieto-Conde; María Del Carmen Chillón; Ana Alfonso-Pierola; Felipe Prosper; Marta Fernandez-Mercado; María José Calasanz
Journal:  PLoS One       Date:  2020-01-24       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.